Long-Term Outcomes of Duodenal Switch (DS) Versus Single Anastomosis Duodeno-Ileostomy with Sleeve Gastrectomy (SADI-S): A Matched Cohort Study
The risk of stroke is cut by more than half in what researchers believe is the largest patient sample size ever for a study on bariatric surgery and its effect on ischemic cerebrovascular disease (96,094 bariatric surgery patients and 1,533,725 matched nonsurgical patients with obesity).
Research suggests that women who have weight loss surgery need to reduce the amount of fat they eat after surgery to reap the full benefit of the procedure and protect their liver function. The study is published ahead of print in the American Journal of Physiology-Endocrinology and Metabolism.
Bariatric surgery can significantly reduce the risk of cancer—and especially obesity-related cancers—by as much as half in certain individuals, according to a study by researchers at Rutgers Robert Wood Johnson Medical School’s Center for Liver Diseases and Liver Masses.
More than half of adults with type 2 diabetes had long-term remission following gastric bypass surgery, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism..
CLEVELAND: A Cleveland Clinic study shows that among patients who have obesity and who tested positive for COVID-19, a past history of bariatric surgery was significantly associated with a lower risk of hospital and intensive care unit admission. The results were published in the journal of Surgery for Obesity and Related Diseases.
While most patients are at least somewhat satisfied with their surgery long-term, satisfaction decreased from 85% to 77% three to seven years post-surgery. Most patients also continue to lead sedentary lives, which contributes to weight regain and negatively affects their mental well-being.
A Cleveland Clinic study shows that 5 to 10 percent of surgically induced weight loss is associated with improved life expectancy and cardiovascular health. In comparison, about 20 percent weight loss is necessary to observe similar benefits with a non-surgical treatment. The findings also show that metabolic surgery may contribute health benefits that are independent of weight loss. The study is published in the October issue of Annals of Surgery.
Obesity is contributing to worse outcomes in people with COVID-19. Dr. Naomi Parrella, medical director of the Rush Center for Weight Loss and Bariatric Surgery, explains how managing your weight can lower your risk for severe COVID symptoms and help you prevent other chronic diseases.
A longstanding theory has suggested that gastric bypass surgery may have unique, weight loss-independent effects in treating type 2 diabetes. But new research from Washington University School of Medicine in St. Louis indicates that weight loss after surgery, rather than the surgery itself, drives metabolic improvements, such as the remission of diabetes.
While the U.S. Centers for Disease Control and Prevention (CDC) advises that people of any age can contract COVID-19, obesity has emerged among the major risk factors for severe cases. With more than 40 percent of Americans classified as obese, experts caution that this is a growing concern.
Pairing bariatric surgery with LVAD heart surgery may be an effective bridge to heart transplant for obese patients.
Shelter-in-place orders to reduce the spread of COVID-19 put unusual strains on people with obesity, making it more difficult for them to eat properly and manage their weight, according to a UT Southwestern study.
Article title: Sleeve gastrectomy enhances glucose utilization and remodels adipose tissue independent of weight loss Authors: David A. Harris, Amir Mina, Dimitrije Cabarkapa, Keyvan Heshmati, Renuka Subramaniam, Alexander S. Banks, Ali Tavakkoli, Eric G. Sheu From the authors: “[Sleeve gastrectomy] induces a…
Patients with extreme obesity are prone to unconscious food impulses and cravings that may make it challenging for them to maintain weight loss after bariatric surgery, according to research that was accepted for presentation at ENDO 2020, the Endocrine Society’s annual meeting, and will be published in a special supplemental section of the Journal of the Endocrine Society.
Most resident physicians training in internal medicine do not feel adequately prepared to manage obesity in their patients, a new survey from a California residency program finds. The results were accepted for presentation at ENDO 2020, the Endocrine Society’s annual meeting, and will be published in a special supplemental section of the Journal of the Endocrine Society.
Obese patients may lose more weight if they undergo bariatric surgery before they develop diabetes, suggests a study accepted for presentation at ENDO 2020, the Endocrine Society’s annual meeting. The research will be published in a special supplemental issue of the Journal of the Endocrine Society.
Although 1 in 7 adults smoke cigarettes the year prior to undergoing weight-loss surgery, nearly all successfully quit at least a month before their operation. However, smoking prevalence steadily climbs to pre-surgery levels within seven years, according to new research.
Post-bariatric hypoglycemia is a profoundly life-altering condition for patients. Having unpredictable hypoglycemia that people can’t detect is really an unsafe situation. Researchers at Joslin Diabetes Center and Harvard John A. Paulson School of Engineering and Applied Sciences have developed a closed-loop system that automatically provides patients with an appropriate, as-needed dose of liquid glucagon to treat this condition.
Which of the two most common bariatric surgeries – gastric sleeve or gastric bypass – has the highest subsequent risk of additional operations or procedures?
Patients struggling with type 2 diabetes and obesity are faced with the decision of whether to receive usual medical care or undergo weight-loss surgery. Now, a new risk calculator developed by Cleveland Clinic researchers can show these patients their risks of developing major health complications over the next 10 years depending on which course of treatment they choose.
The research was presented today as one of the Top 10 studies at the ObesityWeek 2019 international conference in Las Vegas.
Mayo Clinic physicians will present findings at the American College of Gastroenterologists Annual Scientific Meeting, Oct. 25–30 in San Antonio.